Updated: Alnylam’s new Phase 3 ATTR data bring uncertainty to standard of care ambitions

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

bonyf’s 2023 financial statements made available – Biotech Investments

bonyf NV / Key word(s): Annual Results bonyf NV: bonyf’s 2023 financial statements made available 28-Jun-2024 / 17:12 CET/CEST bonyf NV: bonyf’s 2023 financial statements

June 29, 2024

GE HealthCare partners with J&J to push spine imaging system

Dive Brief: GE HealthCare has formed a distribution agreement with Johnson & Johnson to increase use of its OEC 3D Imaging System. The applications of

June 22, 2023

£85 million funding to support the international community in tackling antimicrobial resistance

Funding of £85 million will be announced at a global event to support the international community in tackling the growing threat of antimicrobial resistance.

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.